Phosphoenix raises $1.4M
Phosphoenix announced a Seed round of $1.4M on 18 September 2026. The company operates in HealthTech and is based in Netherlands. It was founded by Hans Brons, CEO. Announced today.
Founder
Hans Brons
CEO, Phosphoenix
Outreach angles
- -Hans Brons leads Phosphoenix, a spin-off from the Netherlands Institute for Neuroscience founded in 2019 by Prof. Pieter Roelfsema, Prof. Xing Chen and Dr. Bert Monna.
- -The company's Fountain Probe packs more than 1,000 microelectrodes into a neural interface designed to restore functional vision by stimulating the brain's lateral geniculate nucleus.
- -Phosphoenix is using this seed round to prepare for first-in-human clinical trials with Amsterdam UMC ahead of a planned Series A.
Signals
SeedHealthcareDeep TechRegulated IndustryB2B
Round details
Company: Phosphoenix
Domain: phosphoenix.nl
Amount: $1.4M
Stage: Seed
Industry: HealthTech
Country: Netherlands
Announced: 18 September 2026
Other HealthTech raises
Recently funded in Netherlands